Indicators as of 2026-08-27 close 935.39: price is mixed against the moving-average ladder (MA5 -0.15%, MA10 -1.74%, MA20 +2.19%, MA50 -2.28%, MA100 +12.55%, MA200 +59.91%), with 10-day slopes MA5 +4.83%, MA10 +8.32%, MA20 +3.56%, MA100 +7.58%, MA200 +6.60% positive and MA50 -0.59% negative. RSI(14) 50.99, neutral. Returns 1w -4.00% / 1m +26.58% / 3m +1.29%; 22.92% below the 52-week high. 20d realized volatility 59.70%; volume ratio 5d/20d 0.74, so recent trade is on fading volume. 1w base rate up 0.5486, sample_size 988, basis individual; overlap-adjusted effective_n 197.6 and z_adj +1.37, which is below 2, so this base rate is not distinguishable from 0.5, is not used as directional evidence, and no base-rate-deviation label is claimed. The base-rate window is about 988 trading days (~3.9y) and is strongly up-regime skewed (1y bucket 0.873, 6m 0.8064), so it is not treated as unconditional, especially with the smoothed US recession probability macro series at 0.60 versus 0.32 prior (regime tag, not used as a direction input). Public news context: 2026 HBM supply reported sold out under multi-year take-or-pay agreements with roughly 100B USD of reported remaining performance obligations through 2030, a reported COO appointment, and a reported lower price target from one broker despite described solid memory demand. The submitted direction is up on the balance of positive 10-day slopes and price above the 20/100/200-day averages. Counter-evidence considered and treated as material: this same up thesis on this name resolved incorrect in the two most recent weekly rounds (t0 2026-08-14 return -0.50%, t0 2026-08-21 return -3.51%), price sits below MA5, MA10 and MA50, the MA50 slope is negative, and volume is fading. Indicator evidence is close to balanced, so confidence is set only marginally above 0.5 and below the 1w base rate itself. Not investment advice.